Telehealth weight loss is a convenient online healthcare service that helps you reach and maintain a healthy weight with medical support from home. It includes a personalized plan based on your health, eating habits, and goals, along with guidance on nutrition, activity, and lifestyle changes. You’ll have regular virtual check-ins with a provider who monitors your progress, answers questions, and adjusts your plan as needed. In some cases, medical treatments may also be included if appropriate. The focus is on safe, steady, and sustainable weight loss with ongoing support and accountability.
Who We Treat
Oral medication (Rybelsus and oral Wegovy)
Compounded weekly injections (semiglutide and trizepizide)
Brand name Weekly injections (Ozempic, Wegovy, Mounjaro, zepbound)
“Some medications may be covered by insurance via comorbidities or insurance-covered weight loss.”
WARNING: ⚠️⚠️
RISK OF THYROID C-CELL TUMORS
In rodents, semaglutide causes dose-dependent and treatment-duration-dependent thyroid C-cell tumors at clinically relevant exposures. It is unknown whether semaglutide causes thyroid C-cell tumors, including medullary thyroid carcinoma (MTC), in humans as human relevance of semaglutide-induced rodent thyroid C-cell tumors has not been determined.
Semaglutide is contraindicated in patients with a personal or family history of MTC or in patients with Multiple Endocrine Neoplasia syndrome type 2 (MEN 2). Counsel patients regarding the potential risk for MTC with the use of semaglutide and inform them of symptoms of thyroid tumors (e.g., a mass in the neck, dysphagia, dyspnea, persistent hoarseness). Routine monitoring of serum calcitonin or using thyroid ultrasound is of uncertain value for early detection of MTC in patients treated with semaglutide.